{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T15:53:17Z","timestamp":1721231597286},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.cpet.2013.10.003","type":"journal-article","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T10:45:23Z","timestamp":1386240323000},"page":"117-127","source":"Crossref","is-referenced-by-count":14,"title":["Standardization and Quantification in FDG-PET\/CT Imaging for Staging and Restaging of Malignant Disease"],"prefix":"10.1016","volume":"9","author":[{"given":"Cristina","family":"G\u00e1mez-Cenzano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Pino-Sorroche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cpet.2013.10.003_bib1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2967\/jnumed.107.047787","article-title":"Recommendations on the use of 18F-FDG PET in oncology","volume":"49","author":"Fletcher","year":"2008","journal-title":"J\u00a0Nucl Med"},{"issue":"21","key":"10.1016\/j.cpet.2013.10.003_bib2","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","article-title":"Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma","volume":"23","author":"Sch\u00f6der","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.cpet.2013.10.003_bib3","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2214\/AJR.11.7560","article-title":"Correlating metabolic activity on 18F-FDG PET\/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients","volume":"198","author":"Rakheja","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.cpet.2013.10.003_bib4","doi-asserted-by":"crossref","first-page":"W365","DOI":"10.2214\/AJR.07.2660","article-title":"18F-FDG PET of common enhancing malignant brain tumors","volume":"190","author":"Kosaka","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cpet.2013.10.003_bib5","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0959-8049(99)00229-4","article-title":"Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European organization for research and treatment of cancer (EORTC) PET study group","volume":"35","author":"Young","year":"1999","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.cpet.2013.10.003_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00259-001-0679-z","article-title":"Is quantitation necessary for oncological PET studies? For","volume":"29","author":"Coleman","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.cpet.2013.10.003_bib7","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1007\/s00259-009-1306-7","article-title":"Methodological considerations in quantification of oncological FDG PET studies","volume":"37","author":"Vriens","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2013.10.003_bib8","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/10428190903040048","article-title":"Report on the first international workshop on interim-PET scan in lymphoma","volume":"50","author":"Meignan","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.cpet.2013.10.003_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/RLU.0b013e318238f51a","article-title":"Comparison of F-18 FDG and C-11 methionine PET\/CT for the evaluation of recurrent primary brain tumors","volume":"37","author":"Tripathi","year":"2012","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2013.10.003_bib10","first-page":"623","article-title":"The applications of PET in clinical oncology","volume":"32","author":"Strauss","year":"1991","journal-title":"J\u00a0Nucl Med"},{"issue":"11","key":"10.1016\/j.cpet.2013.10.003_bib11","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.1993.11.11.2101","article-title":"Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation","volume":"11","author":"Wahl","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2013.10.003_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1148\/radiol.2471070567","article-title":"Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET\/CT","volume":"247","author":"Tateishi","year":"2008","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.cpet.2013.10.003_bib13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.athoracsur.2009.05.083","article-title":"Standard uptake value predicts survival in non-small cell lung cancer","volume":"88","author":"Okereke","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cpet.2013.10.003_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/1471-2407-10-667","article-title":"Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography (18F-FDG-PET\/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report","volume":"10","author":"Namura","year":"2010","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.cpet.2013.10.003_bib15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00277-012-1602-3","article-title":"Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma","volume":"92","author":"Miyazaki","year":"2013","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.cpet.2013.10.003_bib16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2214\/AJR.10.4923","article-title":"A\u00a0systematic review of the factors affecting accuracy of SUV measurements","volume":"195","author":"Adams","year":"2010","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.cpet.2013.10.003_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1095-0397(99)00016-3","article-title":"Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis","volume":"2","author":"Larson","year":"1999","journal-title":"Clin Positron Imaging"},{"issue":"3","key":"10.1016\/j.cpet.2013.10.003_bib18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2967\/jnumed.108.058461","article-title":"18F-FDG PET\/CT as an indicator of progression-free and overall survival in osteosarcoma","volume":"50","author":"Costelloe","year":"2009","journal-title":"J\u00a0Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2013.10.003_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cpet.2013.10.003_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/asheducation.V2012.1.397.3798512","article-title":"Interim PET-CT in the management of diffuse large B-cell lymphoma","volume":"2012","author":"Moskowitz","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.cpet.2013.10.003_bib21","first-page":"135","article-title":"Utilidad de la PET-TC en la valoraci\u00f3n de la respuesta precoz al tratamiento en el linfoma B difuso de c\u00e9lula grandes. Resultados preliminares","volume":"31","author":"Cort\u00e9s Romera","year":"2012","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"3","key":"10.1016\/j.cpet.2013.10.003_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.clinimag.2011.08.012","article-title":"18F-fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic review","volume":"36","author":"Treglia","year":"2012","journal-title":"Clin Imaging"},{"issue":"6","key":"10.1016\/j.cpet.2013.10.003_bib23","first-page":"901","article-title":"18F-FDG PET as a candidate for \u201cqualified biomarker\u201d: functional assessment of treatment response in oncology","volume":"47","author":"Larson","year":"2006","journal-title":"J\u00a0Nucl Med"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2013.10.003_bib24","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumours","volume":"50","author":"Wahl","year":"2009","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2013.10.003_bib25","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1200\/JCO.2009.26.5942","article-title":"Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in advanced-stage diffuse large B-Cell lymphoma","volume":"28","author":"Moskowitz","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2013.10.003_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00259-009-1297-4","article-title":"FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: version 1.0","volume":"37","author":"Boellaard","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2013.10.003_bib27","series-title":"The selection, use, calibration, and quality assurance of radionuclide calibrators used in nuclear medicine","author":"The American Association of Physicist in Medicine","year":"2012"},{"key":"10.1016\/j.cpet.2013.10.003_bib28","series-title":"National Electrical Manufacturers Association. NEMA Standards Publication NU 2-1994. Performance measurements of positron emission tomographs","first-page":"2001","author":"National Electrical Manufacturers Association","year":"1994"},{"key":"10.1016\/j.cpet.2013.10.003_bib29","unstructured":"International Atomic Energy Agency. Quality assurance for PET and PET\/CT Systems IAEA Human Health Series No. 1, Vienna: International Atomic Energy Agency. 2009."},{"issue":"3","key":"10.1016\/j.cpet.2013.10.003_bib30","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s00259-009-1347-y","article-title":"Routine quality control recommendations for nuclear medicine instrumentation","volume":"37","author":"EANM Physics Committee","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2013.10.003_bib31","first-page":"885","article-title":"Procedure guideline for tumor imaging with 18F-FDG PET\/CT 1.0","volume":"47","author":"Delbeke","year":"2006","journal-title":"J\u00a0Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2013.10.003_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/193229680700100204","article-title":"Quality control of self-monitoring of blood glucose: why and how?","volume":"1","author":"Solnica","year":"2007","journal-title":"J\u00a0Diabetes Sci Technol"},{"key":"10.1016\/j.cpet.2013.10.003_bib33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cccn.2004.06.010","article-title":"Accuracy of the Easytouch blood glucose self-monitoring system: a study of 516 cases","volume":"349","author":"Dai","year":"2004","journal-title":"Clin Chim Acta"},{"issue":"11","key":"10.1016\/j.cpet.2013.10.003_bib34","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.2967\/jnumed.111.089326","article-title":"Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET\/CT","volume":"52","author":"Fox","year":"2011","journal-title":"J\u00a0Nucl Med"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2013.10.003_bib35","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.2967\/jnumed.108.057182","article-title":"Standards for PET image acquisition and quantitative data analysis","volume":"50","author":"Boellaard","year":"2009","journal-title":"J\u00a0Nucl Med"},{"issue":"41","key":"10.1016\/j.cpet.2013.10.003_bib36","first-page":"1","article-title":"FDG dose extravasations in PET\/CT: frequency and impact on SUV measurements","volume":"1","author":"Osman","year":"2011","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2013.10.003_bib37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4103\/0972-3919.106703","article-title":"New axillary lymph nodal F-18 fluoro-deoxy glucose uptake in an interim positron emission tomography scan \u2013 not always a sign of disease progression","volume":"26","author":"Manohar","year":"2011","journal-title":"Indian J Nucl Med"},{"issue":"11","key":"10.1016\/j.cpet.2013.10.003_bib38","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/RLU.0b013e318266cbdb","article-title":"FDG injection site extravasation: potential pitfall of misinterpretation and missing metastases","volume":"37","author":"Sonoda","year":"2012","journal-title":"Clin Nucl Med"},{"issue":"10","key":"10.1016\/j.cpet.2013.10.003_bib39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12149-007-0068-1","article-title":"SUV correction for injection errors in FDG-PET examination","volume":"21","author":"Miyashita","year":"2007","journal-title":"Ann Nucl Med"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2013.10.003_bib40","first-page":"115P","article-title":"Impact of FDG extravasation on SUV measurements in clinical PET\/CT. Should we routinely scan the injection site?","volume":"47","author":"Hall","year":"2006","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2013.10.003_bib41","doi-asserted-by":"crossref","unstructured":"de la Prieta R. Free software for pet imaging, positron emission tomography - current clinical and research aspects. In: Hsieh CH, editor. 2012. ISBN: 978-953-307-824-3, InTech, doi:10.5772\/31882. Available at: http:\/\/www.intechopen.com\/books\/positron-emission-tomography-current-clinical-and-research-aspects\/free-software-for-pet-imaging. Accessed 2012.","DOI":"10.5772\/31882"},{"issue":"6","key":"10.1016\/j.cpet.2013.10.003_bib42","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2967\/jnumed.106.035774","article-title":"Partial-volume effect in PET tumor imaging","volume":"48","author":"Soret","year":"2007","journal-title":"J\u00a0Nucl Med"},{"issue":"6","key":"10.1016\/j.cpet.2013.10.003_bib43","first-page":"1059","article-title":"Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials","volume":"47","author":"Shankar","year":"2006","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2013.10.003_bib44","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00259-005-1784-1","article-title":"PET\/CT with intravenous contrast can be used for PET attenuation correction in cancer patients","volume":"32","author":"Berthelsen","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2013.10.003_bib45","first-page":"283","article-title":"Application of intravenous contrast in PET\/CT: does it really introduce significant attenuation correction error?","volume":"46","author":"Yau","year":"2005","journal-title":"J\u00a0Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2013.10.003_bib46","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2214\/AJR.06.0813","article-title":"Practical approach to diagnostic CT combined with PET","volume":"188","author":"Wong","year":"2007","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.cpet.2013.10.003_bib47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cpet.2007.08.002","article-title":"Strategies for motion tracking and correction in PET","volume":"2","author":"Rahmim","year":"2007","journal-title":"PET Clin"},{"issue":"3","key":"10.1016\/j.cpet.2013.10.003_bib48","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11307-010-0394-x","article-title":"Detection of hepatic metastases using dual-time-point FDG PET\/CT scans in patients with colorectal cancer","volume":"13","author":"Lee","year":"2011","journal-title":"Mol Imaging Biol"},{"issue":"4","key":"10.1016\/j.cpet.2013.10.003_bib49","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.semnuclmed.2012.02.003","article-title":"Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity","volume":"42","author":"Schillaci","year":"2012","journal-title":"Semin Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2013.10.003_bib50","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00259-006-0224-1","article-title":"Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters","volume":"34","author":"Westerterp","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.cpet.2013.10.003_bib51","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2967\/jnumed.108.057455","article-title":"Qualification of PET scanners for use in multicenter cancer clinical trials: the American College of Radiology Imaging Network experience","volume":"50","author":"Scheuermann","year":"2009","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2013.10.003_bib52","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1007\/s00259-008-0874-2","article-title":"The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials","volume":"35","author":"Boellaard","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 4","key":"10.1016\/j.cpet.2013.10.003_bib53","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0959-8049(11)72621-1","article-title":"Initial experience with the EANM accreditation procedure of FDG PET\/CT devices","volume":"47","author":"Boellaard","year":"2011","journal-title":"Eur J Cancer"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859813001016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859813001016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T12:20:54Z","timestamp":1597148454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859813001016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1556859813001016"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2013.10.003","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}